Benitec Biopharma Inc. (BNTC)
NASDAQ · Healthcare
Benitec Biopharma Inc. Income Statement 2019–2024
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 0 | 75,000 | 73,000 | 59,000 | 102,000 | 12.2M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -22.5M | -19.1M | -17.9M | -13.6M | -8.3M | 2.6M |
| EBITDA | -22.4M | -18.9M | -17.7M | -13.4M | -8.1M | 2.7M |
| Net Income | -21.8M | -19.6M | -18.2M | -13.9M | -8.3M | 2.6M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 18M | 1M | 0M | 4M | 1M | 1M |
Benitec Biopharma Inc. Income Statement — FAQ
Benitec Biopharma Inc. (BNTC) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BNTC's income statement history?
The chart and table above show Benitec Biopharma Inc.'s income statement by year and by quarter, including the growth rate.